Readoutin 135d
Boehringer Ingelheim — Nerandomilast
Phase 3 primary completion: A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases.
- Date
- Apr 2027
- Type
- Readout
- Indication
- Interstitial Lung Diseases
Readoutin 135d
Phase 3 primary completion: A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.